Does Ibuprofen Worsen COVID-19?

Drug Saf. 2020 Jul;43(7):611-614. doi: 10.1007/s40264-020-00953-0.

Authors

Nicholas Moore¹, Bruce Carleton², Patrick Blin³, Pauline Bosco-Levy³, Cecile Droz³

Affiliations

¹ Bordeaux PharmacoEpi, INSEMR CIC 1401, Universityd of Bordeaux, 146 rue Leo Saignat, 33076, Bordeaux, France. Nicholas.moore@u-bordeaux.fr.
² Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
³ Bordeaux PharmacoEpi, INSEMR CIC 1401, Universityd of Bordeaux, 146 rue Leo Saignat, 33076, Bordeaux, France.

No abstract available

Publication types

Editorial

MeSH terms

Acute Disease / therapy
Angiotensin-Converting Enzyme 2
Anti-Inflammatory Agents, Non-Steroidal / pharmacology
Betacoronavirus / physiology
COVID-19
Coronavirus Infections* / epidemiology
Coronavirus Infections* / metabolism
Coronavirus Infections* / prevention & control
Humans
Ibuprofen / pharmacology*
Pandemics* / prevention & control
Peptidyl-Dipeptidase A / metabolism*
Pneumonia, Viral* / epidemiology
Pneumonia, Viral* / metabolism
Pneumonia, Viral* / prevention & control
Risk Assessment
SARS-CoV-2
Up-Regulation / drug effects
Virus Internalization / drug effects*

Substances

Anti-Inflammatory Agents, Non-Steroidal
Peptidyl-Dipeptidase A
ACE2 protein, human
Angiotensin-Converting Enzyme 2
Ibuprofen